Bosnia and Herzegovina vs Italy: Share of E. coli infections resistant to cephalosporins
Bosnia and Herzegovina
26.8%
in 2022
Italy
26.5%
in 2022
Bosnia and Herzegovina rank
25th
Italy rank
26th
Share of E. coli infections resistant to cephalosporins over time
- Bosnia and Herzegovina
- Italy
How they compare
Bosnia and Herzegovina currently reports 26.8% against 26.5% in Italy, a difference of 0.3%.
The two have swapped places 1 time across 5 shared years of data; in 2018 it was Italy ahead.
Bosnia and Herzegovina ranks 25th and Italy ranks 26th of 46 countries.
Italy has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20.3% | 31.2% | 10.9% | Italy |
| 2020s | 26.4% | 26.6% | 0.2% | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Bosnia and Herzegovina or Italy?
- Bosnia and Herzegovina, at 26.8% against 26.5% in Italy as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Bosnia and Herzegovina and Italy?
- 0.3%, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Italy?
- 5 years are reported by both, from 2018 to 2022.
- How do Bosnia and Herzegovina and Italy rank globally for share of e. coli infections resistant to cephalosporins?
- Bosnia and Herzegovina ranks 25th and Italy ranks 26th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).